Acute myeloid leukemia following prolonged iodine-131 therapy for metastatic thyroid carcinoma.
نویسندگان
چکیده
Reversible Bleaching of Chlorophyll in vivo: J. W. Coleman, A. S. Holt, E. Rabinowitch .... ...................... 795 Clot-Retraction Promoting Factor (Retractin) in Platelets and Tissues: S. I. Magalini and M. Stefanini ..... ...................... 796 Inhibition of Aerobic Phosphorylation and Pasteur Reaction by an Adrenal-Cortical Extract: Z. Miller ..... ........................ 797 Tergal and Cercal Secretion of Blatta orientalis L.: L. M. Roth and W. H. Stahl ....... ............................... 798 Distribution of Alpha-Radioactivity in Certain Forest Types: J. T. Curtis and R. Dix ........ .................................. 799 Acute Myeloid Leukemia Following Prolonged Iodine-131 Therapy for Metastatic Thyroid Carcinoma: S. M. Seidlin et al ................... Palynological Study of Pleistocene Deposits on Banks Island, Northwest Territories, Canada: J. Terasmae .... .................... 801
منابع مشابه
A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
Radioiodine is regularly used in the treatment of thyroid cancer to eliminate residual malignant tissue after thyroidectomy and to treat metastasis. Because of the low dose of radioiodine used to treat thyroid cancer patients, leukemia is an uncommon complication of exposure to radioiodine. Here, we present a patient who developed therapy-related acute myeloid leukemia with inv(16)(p13.1q22);CB...
متن کاملAcute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid.
Radioactive iodine (RAI) therapy plays an important role in the management of thyroid malignancies. Leukemia is a very rare complication of radioactive therapy. There are very few case reports with doses below 100 mCi causing leukemia. We report a case of papillary carcinoma of the thyroid treated with 80 mCi RAI who later developed acute myeloid leukemia. Thus, all patients with thyroid carcin...
متن کاملChronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
A 27-year-old male developed Philadelphia chromosome-positive chronic myeloid leukemia (CML) 13 years after a first dose of radioiodine (131I) therapy for papillary thyroid carcinoma. He had received a cumulative 131I dose of 670 mCi, in 8 divided doses over 8 years, up to April 1998, for ablation of 131I avid tissues over the anterior neck region. The leukemogenic potential of radioactive iodi...
متن کاملAn Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine
The standard therapy for thyroid cancer is total or near total thyroidectomy, followed by the administration of radioactive iodine for remnant ablation or residual disease. Patients with radioiodine therapy are predisposed to second malignant neoplasms in organs such as central nervous system (CNS), breast, prostate, kidney, bone marrow, salivary gland, and digestive tract. Exposure to carcinog...
متن کاملRetrospective analysis of I-131 therapy in patients with follicular carcinoma of the thyroid [Persian]
In research institute for nuclear medicine (Tehran University of Medical Sciences) 50 patients with follicular thyroid carcinoma were evaluted retrospectively. The purpose of the study was assesment of the response of iodine-131 therapy. The best result were achieved when the patient treated with iodine-131 for the first time, in the 4th decade of life, with total thyroidectomy and no met...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Science
دوره 123 3201 شماره
صفحات -
تاریخ انتشار 1956